1. Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology

2. TUBERCULOSIS: caused by mycobacterium avium

3. Problems in Chemotherapy. -grow more slowly than other bacteria - develop resistance rapidly -intracellular pathogens

4. Chemotherapy of T.B. "First-line" drugs  isoniazid  rifamycins  ethambutol  pyrazinamide

5. second-line  Aminoglycosides  ethionamide  aminosalicylic acid  cycloserine  capreomycin  fluoroquinolones  macrolides

6. Isoniazid Mechanism of Action PRODRUG mycobacterial catalase - peroxidase(KatG) active metabolite MYCOLIC ACIDS

7. Antibacterial Activity: -bacteriostatic&-bactericidal

8. Bacterial Resistance:

9. Pharmacokinetics -Absorption-Distribution -Metabolism: fast slow -excretion

10. Adverse Reactions: A.immunological -Fever -skin rashes -Drug-induced systemic lupus erythematosus

11. B. direct toxicity: -Isoniazid -induced hepatitis -Peripheral neuropathy

12. Rifamycins: Rifampin, rifabutin and rifapentine Mechanism of action RNA SYNTHESIS Rifampin RNA polymerase

13. Antimicrobial spectrum Rifampin is bactericidal for both intracellular and extracellular mycobacteria, including M. tuberculosis, and atypical mycobacteria, such as M. kansasii. It is effective against many gram-positive and gram-negative organisms.

14. Resistance

15. Pharmacokinetics -Absorption-Distribution -Metabolism enterohepatic cycling

16. hepatic mixed-function oxidases, (autoinduction).

17. Adverse effects: -nausea, vomiting, and rash. -increased incidence of severe hepatic dysfunction when rifampin is administered alone or concomitantly with isoniazid. -a flu-like syndrome is associated with fever, chills, and myalgias

18. -Drug interactions: Because rifampin can induce a number of cytochrome P450 enzymes, it can decrease the half-lives of other drugs that are coadministered and metabolized by this system. This may lead to higher dosage requirements for these agents.

19. Pyrazinamide Mechanism of action: Pyrazinamidase Pyrazinamide pyrazinoic acid,

20. Antimicrobial spectrum: bactericidal to only actively dividing organisms.

21. Resistance

22. Pharmacokinetics -Absorption-Distribution-Metabolism-excretion

23. Adverse effects: Urate retention can also occur and may precipitate a gouty attack.

24. Ethambutol Mechanism of action Ethambutol inhibits arabinosyl transferase Ethambutol Arabinosyl -T Arabinogalactan molecules

25. Antimicrobial spectrum bacteriostatic and specific for most strains of M. tuberculosis and M. kansasii.

26. Resistance Resistance is not problem if the drug is employed with other antitubercular agents.

27. Pharmacokinetics Absorbed on oral administration, ethambutol is well distributed throughout the body. Penetration into the central nervous system (CNS) is therapeutically adequate in tuberculous meningitis. Both parent drug and metabolites are excreted by glomerular filtration and tubular secretion.

28. Adverse effects -optic neuritis -urate excretion is decreased by the drug; thus, gout may be exacerbated

29. Alternate second-line drugs -Streptomycin: -Capreomycin:

30. Cycloserine Mechanism of action antagonize the steps in bacterial cell wall synthesis involving D-alanine.

31. Antimicrobial spectrum - tuberculostatic agent

32. Pharmacokinetics -orally effective, -It distributes well throughout body fluids, including the CSF. Cycloserine is metabolized, and both parent and metabolite are excreted in urine. Accumulation occurs with renal insufficiency.

33. Adverse effects involve CNS disturbances, and epileptic seizure activity may be exacerbated. Peripheral neuropathies are also a problem, but they respond to pyridoxine.

34. Leprosy; caused by Mycobacterium leprae.

35. Chemotherapy The triple-drug regimen of dapsone, clofazimine, and rifampin for 6 to 24 months.

36. Dapsone Mechanism of Action. Dapsone is structurally related to the sulfonamides and similarly inhibits folate synthesis.

37. Antibacterial Activity is bacteriostatic for Mycobacterium leprae, but resistant strains are encountered.

38. Pharmacokinetics The drug is well absorbed from the gastrointestinal tract and is distributed throughout the body, with high levels concentrated in the skin. The parent drug enters the enterohepatic circulation and undergoes hepatic acetylation. Both parent drug and metabolites are eliminated through the urine.

39. Adverse reactions -hemolysis-methemoglobinemia. - peripheral neuropathy

40. Clofazimine Mechanism of Action -binds to DNA and prevents it from serving as a template for future DNA replication. -Its redox properties may lead to the generation of cytotoxic oxygen radicals that are also toxic to the bacteria.

41. Antibacterial Activity Clofazimine is bactericidal to M. leprae

42. Pharmacokinetics Following oral absorption, the drug accumulates in tissues, allowing intermittent therapy, but it does not enter the CNS.

43. Adverse Reactions -red-brown discoloration of the skin. -enteritis

44. Rifampin